New study aims to predict lung outcomes in sarcoidosis patients

NCT ID NCT05567133

Recruiting now Knowledge-focused Sponsor: University of California, San Francisco Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is developing prediction models to forecast lung function changes in people with sarcoidosis, a condition that causes inflammation in the lungs. Researchers will collect clinical data and blood markers from 200 adults during routine clinic visits. The goal is to create tools that help doctors personalize care and anticipate pulmonary complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to better tools for doctors to predict how sarcoidosis will affect a patient's lungs, helping guide treatment decisions.
What could go wrong: This is an observational study, not a treatment trial. The prediction models may not be accurate enough for widespread use and will need further validation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SARCOIDOSIS, PULMONARY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pulmonary sarcoidosis sarcoidosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SARCOIDOSIS, PULMONARY

Contacts and locations

Locations

UT Southwestern
RECRUITING

Dallas, Texas, 75390, United States
University of Maryland
RECRUITING

Baltimore, Maryland, 21201, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.